Work

Endogenous Osteonectin/SPARC/BM-40 Expression Inhibits MDA-MB-231 Breast Cancer Cell Metastasis

Year: 2005

Type: article

Source: Cancer Research

DOI: 10.1158/0008-5472.can-05-0807

Authors: Jennifer E. Koblinski, Benjamin R. Kaplan-Singer, Sherilyn J. VanOsdol, Michael Wu, Jean A. Engbring, Songlin Wang, Corinne M. Goldsmith, John T. Piper, Jaroslav G. Vostal, John F. Harms, Danny R. Welch, Hynda K. Kleinman

Institutions: Capital Medical University, National Institutes of Health, National Institute of Dental and Craniofacial Research, Center for Biologics Evaluation and Research, United States Food and Drug Administration, Pennsylvania State University, University of Alabama, University of Alabama at Birmingham

Language: English

Topic: Bone and Dental Protein Studies

Subfield: Rheumatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Cancer Institute

Awards: G2263569656, Molecular regulation of breast cancer metastasis, G525630276, Role of Osteonectin in Breast Cancer Bone Metastasis

OpenAlex ID: W2171137965

FWCI: 5.429

Cites: 56

Cited by: 112

Related to: 10